메뉴 건너뛰기




Volumn 4, Issue 2, 2009, Pages 87-94

Natriuretic peptide guided heart failure management

Author keywords

Coronary artery disease; Heart failure; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NESIRITIDE; PLACEBO; TRANDOLAPRIL;

EID: 68449088769     PISSN: 15748847     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488409788184945     Document Type: Review
Times cited : (10)

References (99)
  • 1
    • 0033971364 scopus 로고    scopus 로고
    • Predictors of readmission among elderly survivors of admission with heart failure
    • Krumholz HM, Chen YT, Wang Y, et al. Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J 2000; 139: 72-77.
    • (2000) Am Heart J , vol.139 , pp. 72-77
    • Krumholz, H.M.1    Chen, Y.T.2    Wang, Y.3
  • 2
    • 0035846616 scopus 로고    scopus 로고
    • Hunt SA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 2001; 104: 2996-3007.
    • Hunt SA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 2001; 104: 2996-3007.
  • 3
    • 20044379730 scopus 로고    scopus 로고
    • Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology
    • Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 384-416.
    • (2005) Eur Heart J , vol.26 , pp. 384-416
    • Nieminen, M.S.1    Bohm, M.2    Cowie, M.R.3
  • 4
    • 0037005813 scopus 로고    scopus 로고
    • Confirmation of a heart failure epidemic: Findings from the Resource Utilization Among Congestive Heart Failure (REACH) study
    • McCullough PA, Philbin EF, Spertus JA, et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002; 39: 60-69.
    • (2002) J Am Coll Cardiol , vol.39 , pp. 60-69
    • McCullough, P.A.1    Philbin, E.F.2    Spertus, J.A.3
  • 5
    • 0037206359 scopus 로고    scopus 로고
    • Heart failure - an epidemic of uncertain proportions
    • Redfield MM. Heart failure - an epidemic of uncertain proportions. N Engl J Med 2002; 347: 1442-1444.
    • (2002) N Engl J Med , vol.347 , pp. 1442-1444
    • Redfield, M.M.1
  • 6
    • 47849125899 scopus 로고    scopus 로고
    • Heart failure-related hospitalization in the U.S., 1979 to 2004
    • Fang J, Mensah GA, Croft JB, et al. Heart failure-related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol 2008; 52: 428-434.
    • (2008) J Am Coll Cardiol , vol.52 , pp. 428-434
    • Fang, J.1    Mensah, G.A.2    Croft, J.B.3
  • 7
    • 0028359997 scopus 로고
    • Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
    • Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.
    • (1994) Circulation , vol.90 , pp. 195-203
    • Yasue, H.1    Yoshimura, M.2    Sumida, H.3
  • 8
    • 0026722911 scopus 로고
    • Molecular biology of the natriuretic peptides and their receptors
    • Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation 1992; 86: 1081-1088.
    • (1992) Circulation , vol.86 , pp. 1081-1088
    • Koller, K.J.1    Goeddel, D.V.2
  • 9
    • 0027213055 scopus 로고
    • Brain natriuretic peptide: Natriuretic and endocrine effects in essential hypertension
    • Richards AM, Crozier IG, Holmes SJ, et al. Brain natriuretic peptide: natriuretic and endocrine effects in essential hypertension. J Hypertens 1993; 11: 163-170.
    • (1993) J Hypertens , vol.11 , pp. 163-170
    • Richards, A.M.1    Crozier, I.G.2    Holmes, S.J.3
  • 10
    • 0033813343 scopus 로고    scopus 로고
    • Deconvolution analysis of cardiac natriuretic peptides during acute volume overload
    • Pemberton CJ, Johnson ML, Yandle TG, et al. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension 2000; 36: 355-359.
    • (2000) Hypertension , vol.36 , pp. 355-359
    • Pemberton, C.J.1    Johnson, M.L.2    Yandle, T.G.3
  • 11
    • 33645030807 scopus 로고    scopus 로고
    • NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: Results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy
    • Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J 2006; 27: 839-845.
    • (2006) Eur Heart J , vol.27 , pp. 839-845
    • Chen, A.A.1    Wood, M.J.2    Krauser, D.G.3
  • 12
    • 33947722230 scopus 로고    scopus 로고
    • Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure
    • Corell P, Gustafsson F, Kistorp C, et al. Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure. Int J Cardiol 2 2007; 117: 395-402.
    • (2007) Int J Cardiol , vol.2 , Issue.117 , pp. 395-402
    • Corell, P.1    Gustafsson, F.2    Kistorp, C.3
  • 13
    • 33845293260 scopus 로고    scopus 로고
    • Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study
    • Morello A, Lloyd-Jones DM, Chae CU, et al. Association of atrial fibrillation and amino-terminal pro-brain natriuretic peptide concentrations in dyspneic subjects with and without acute heart failure: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. Am Heart J 2007; 153: 90-97.
    • (2007) Am Heart J , vol.153 , pp. 90-97
    • Morello, A.1    Lloyd-Jones, D.M.2    Chae, C.U.3
  • 14
    • 33750303897 scopus 로고    scopus 로고
    • Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: The role of biologic variation in the interpretation of results
    • Wu AH. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. Am Heart J 2006; 152: 828-834.
    • (2006) Am Heart J , vol.152 , pp. 828-834
    • Wu, A.H.1
  • 15
    • 33847021875 scopus 로고    scopus 로고
    • Long-term clinical variation of NT-proBNP in stable chronic heart failure patients
    • Schou M, Gustafsson F, Kjaer A, et al. Long-term clinical variation of NT-proBNP in stable chronic heart failure patients. Eur Heart J 2007; 28: 177-182.
    • (2007) Eur Heart J , vol.28 , pp. 177-182
    • Schou, M.1    Gustafsson, F.2    Kjaer, A.3
  • 16
    • 33751018560 scopus 로고    scopus 로고
    • Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure
    • Araujo JP, Azevedo A, Lourenco P, et al. Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure. Am J Cardiol 2006; 98: 1248-1250.
    • (2006) Am J Cardiol , vol.98 , pp. 1248-1250
    • Araujo, J.P.1    Azevedo, A.2    Lourenco, P.3
  • 17
    • 0041508543 scopus 로고    scopus 로고
    • Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure
    • Wu AH, Smith A, Wieczorek S, et al. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 2003; 92: 628-631.
    • (2003) Am J Cardiol , vol.92 , pp. 628-631
    • Wu, A.H.1    Smith, A.2    Wieczorek, S.3
  • 18
    • 7044284668 scopus 로고    scopus 로고
    • High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure
    • Bruins S, Fokkema MR, Romer JW, et al. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 2004; 50: 2052-2058.
    • (2004) Clin Chem , vol.50 , pp. 2052-2058
    • Bruins, S.1    Fokkema, M.R.2    Romer, J.W.3
  • 19
    • 33749429825 scopus 로고    scopus 로고
    • Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function
    • Cioffi G, Tarantini L, Stefenelli C, et al. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function. J Card Fail 2006; 12: 608-615.
    • (2006) J Card Fail , vol.12 , pp. 608-615
    • Cioffi, G.1    Tarantini, L.2    Stefenelli, C.3
  • 20
    • 33847673577 scopus 로고    scopus 로고
    • Decrease in NTproBNP plasma levels indicates clinical improvement of acute decompensated heart failure
    • Di Somma S, Magrini L, Mazzone M, et al. Decrease in NTproBNP plasma levels indicates clinical improvement of acute decompensated heart failure. Am J Emerg Med 2007; 25: 335-339.
    • (2007) Am J Emerg Med , vol.25 , pp. 335-339
    • Di Somma, S.1    Magrini, L.2    Mazzone, M.3
  • 21
    • 24944578545 scopus 로고    scopus 로고
    • Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure
    • Fitzgerald RL, Cremo R, Gardetto N, et al. Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure. Am Heart J 2005; 150: 471-477.
    • (2005) Am Heart J , vol.150 , pp. 471-477
    • Fitzgerald, R.L.1    Cremo, R.2    Gardetto, N.3
  • 22
    • 33750803702 scopus 로고    scopus 로고
    • Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure
    • Braunschweig F, Fahrleitner-Pammer A, Mangiavacchi M, et al. Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure. Eur J Heart Fail 2006; 8: 797-803.
    • (2006) Eur J Heart Fail , vol.8 , pp. 797-803
    • Braunschweig, F.1    Fahrleitner-Pammer, A.2    Mangiavacchi, M.3
  • 23
    • 0141818324 scopus 로고    scopus 로고
    • Effects of the addition of a low dose of spironolactone on brain natriuretic peptide plasma level and cardiopulmonary function in patients with moderate congestive heart failure
    • Feola M, Menardi E, Ribichini F, et al. Effects of the addition of a low dose of spironolactone on brain natriuretic peptide plasma level and cardiopulmonary function in patients with moderate congestive heart failure. Med Sci Monit 2003; 9: CR341-345.
    • (2003) Med Sci Monit , vol.9
    • Feola, M.1    Menardi, E.2    Ribichini, F.3
  • 24
    • 0037032257 scopus 로고    scopus 로고
    • Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: Results from the RALES neurohormonal substudy
    • Rousseau MF, Gurne O, Duprez D, et al. Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy. J Am Coll Cardiol 2002; 40: 1596-1601.
    • (2002) J Am Coll Cardiol , vol.40 , pp. 1596-1601
    • Rousseau, M.F.1    Gurne, O.2    Duprez, D.3
  • 25
    • 33947321444 scopus 로고    scopus 로고
    • Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker
    • Berry C, Murphy NF, De Vito G, et al. Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker. Eur J Heart Fail 2007; 9: 429-434.
    • (2007) Eur J Heart Fail , vol.9 , pp. 429-434
    • Berry, C.1    Murphy, N.F.2    De Vito, G.3
  • 26
    • 0035312341 scopus 로고    scopus 로고
    • Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure
    • Tsutamoto T, Wada A, Maeda K, et al. Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol 2001; 37: 1228-1233.
    • (2001) J Am Coll Cardiol , vol.37 , pp. 1228-1233
    • Tsutamoto, T.1    Wada, A.2    Maeda, K.3
  • 27
    • 0033788738 scopus 로고    scopus 로고
    • Effect of angiotensin-converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic peptide in elderly hypertensives with left venticular hypertrophy
    • Kohno M, Minami M, Kano H, et al. Effect of angiotensin-converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic peptide in elderly hypertensives with left venticular hypertrophy. Metabolism 2000; 49: 1356-1360.
    • (2000) Metabolism , vol.49 , pp. 1356-1360
    • Kohno, M.1    Minami, M.2    Kano, H.3
  • 28
    • 11144355879 scopus 로고    scopus 로고
    • Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure
    • Yasumura Y, Miyatake K, Okamoto H, et al. Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure. Circ J 2004; 68: 361-366.
    • (2004) Circ J , vol.68 , pp. 361-366
    • Yasumura, Y.1    Miyatake, K.2    Okamoto, H.3
  • 29
    • 0037432301 scopus 로고    scopus 로고
    • Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
    • Anand IS, Fisher LD, Chiang YT, et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003; 107: 1278-1283.
    • (2003) Circulation , vol.107 , pp. 1278-1283
    • Anand, I.S.1    Fisher, L.D.2    Chiang, Y.T.3
  • 30
    • 33645074956 scopus 로고    scopus 로고
    • Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure
    • Davis ME, Richards AM, Nicholls MG, et al. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure. Circulation. 2006; 113: 977-985.
    • (2006) Circulation , vol.113 , pp. 977-985
    • Davis, M.E.1    Richards, A.M.2    Nicholls, M.G.3
  • 31
    • 0034142256 scopus 로고    scopus 로고
    • Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy: The randomized evaluation of strategies for left ventricular dysfunction pilot study
    • Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy: the randomized evaluation of strategies for left ventricular dysfunction pilot study. Circulation 2000; 101: 378-384.
    • (2000) Circulation , vol.101 , pp. 378-384
  • 32
    • 0034894106 scopus 로고    scopus 로고
    • Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction
    • Stanek B, Frey B, Hulsmann M, et al. Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction. J Am Coll Cardiol 2001; 38: 436-442.
    • (2001) J Am Coll Cardiol , vol.38 , pp. 436-442
    • Stanek, B.1    Frey, B.2    Hulsmann, M.3
  • 33
    • 1642494797 scopus 로고    scopus 로고
    • Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: The CAPRICORN Echo Substudy
    • Doughty RN, Whalley GA, Walsh HA, et al. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation 2004; 109: 201-206.
    • (2004) Circulation , vol.109 , pp. 201-206
    • Doughty, R.N.1    Whalley, G.A.2    Walsh, H.A.3
  • 34
    • 0028884808 scopus 로고
    • Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: A double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker
    • Sanderson JE, Chan WW, Hung YT, et al. Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker. Br Heart J 1995; 74: 502-507.
    • (1995) Br Heart J , vol.74 , pp. 502-507
    • Sanderson, J.E.1    Chan, W.W.2    Hung, Y.T.3
  • 35
    • 10744223176 scopus 로고    scopus 로고
    • NT-proBNP in severe chronic heart failure: Rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy
    • Hartmann F, Packer M, Coats AJ, et al. NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy. Eur J Heart Fail 2004; 6: 343-350.
    • (2004) Eur J Heart Fail , vol.6 , pp. 343-350
    • Hartmann, F.1    Packer, M.2    Coats, A.J.3
  • 36
    • 0035369468 scopus 로고    scopus 로고
    • Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: Prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group
    • Richards AM, Doughty R, Nicholls MG, et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. J Am Coll Cardiol 2001; 37: 1781-1787.
    • (2001) J Am Coll Cardiol , vol.37 , pp. 1781-1787
    • Richards, A.M.1    Doughty, R.2    Nicholls, M.G.3
  • 37
    • 20844457770 scopus 로고    scopus 로고
    • Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: A substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial
    • Hartmann F, Packer M, Coats AJ, et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 2004; 110: 1780-1786.
    • (2004) Circulation , vol.110 , pp. 1780-1786
    • Hartmann, F.1    Packer, M.2    Coats, A.J.3
  • 38
    • 4944251606 scopus 로고    scopus 로고
    • Combined endurance/ resistance training reduces NT-proBNP levels in patients with chronic heart failure
    • Conraads VM, Beckers P, Vaes J, et al. Combined endurance/ resistance training reduces NT-proBNP levels in patients with chronic heart failure. Eur Heart J 2004; 25: 1797-1805.
    • (2004) Eur Heart J , vol.25 , pp. 1797-1805
    • Conraads, V.M.1    Beckers, P.2    Vaes, J.3
  • 39
    • 2442693775 scopus 로고    scopus 로고
    • Brain natriuretic peptide kinetics during dynamic exercise in patients with chronic heart failure
    • Kruger S, Graf J, Merx MW, et al. Brain natriuretic peptide kinetics during dynamic exercise in patients with chronic heart failure. Int J Cardiol 2004; 95: 49-54.
    • (2004) Int J Cardiol , vol.95 , pp. 49-54
    • Kruger, S.1    Graf, J.2    Merx, M.W.3
  • 40
    • 33646175035 scopus 로고    scopus 로고
    • Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure
    • Passino C, Severino S, Poletti R, et al. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. J Am Coll Cardiol 2006; 47: 1835-1839.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 1835-1839
    • Passino, C.1    Severino, S.2    Poletti, R.3
  • 41
    • 4644233233 scopus 로고    scopus 로고
    • Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: A randomized controlled trial
    • Yeh GY, Wood MJ, Lorell BH, et al. Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial. Am J Med 2004; 117: 541-548.
    • (2004) Am J Med , vol.117 , pp. 541-548
    • Yeh, G.Y.1    Wood, M.J.2    Lorell, B.H.3
  • 42
    • 34547728666 scopus 로고    scopus 로고
    • Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony
    • Fruhwald FM, Fahrleitner-Pammer A, Berger R, et al. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. Eur Heart J 2007; 28: 1592-1597.
    • (2007) Eur Heart J , vol.28 , pp. 1592-1597
    • Fruhwald, F.M.1    Fahrleitner-Pammer, A.2    Berger, R.3
  • 43
    • 0037130155 scopus 로고    scopus 로고
    • Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
    • Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
    • (2002) N Engl J Med , vol.347 , pp. 161-167
    • Maisel, A.S.1    Krishnaswamy, P.2    Nowak, R.M.3
  • 44
    • 20144388239 scopus 로고    scopus 로고
    • The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study
    • Januzzi JL, Jr., Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study. Am J Cardiol 2005; 95: 948-954.
    • (2005) Am J Cardiol , vol.95 , pp. 948-954
    • Januzzi Jr., J.L.1    Camargo, C.A.2    Anwaruddin, S.3
  • 45
    • 30744458817 scopus 로고    scopus 로고
    • NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: An international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study
    • Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006; 27: 330-337.
    • (2006) Eur Heart J , vol.27 , pp. 330-337
    • Januzzi, J.L.1    van Kimmenade, R.2    Lainchbury, J.3
  • 46
    • 33646793595 scopus 로고    scopus 로고
    • Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea
    • Mueller C, Laule-Kilian K, Schindler C, et al. Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea. Arch Intern Med 2006; 166: 1081-1087.
    • (2006) Arch Intern Med , vol.166 , pp. 1081-1087
    • Mueller, C.1    Laule-Kilian, K.2    Schindler, C.3
  • 47
    • 34250723829 scopus 로고    scopus 로고
    • N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: Primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study
    • Moe GW, Howlett J, Januzzi JL, et al. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation 2007; 115: 3103-3110.
    • (2007) Circulation , vol.115 , pp. 3103-3110
    • Moe, G.W.1    Howlett, J.2    Januzzi, J.L.3
  • 48
    • 1442265589 scopus 로고    scopus 로고
    • Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea
    • Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea. N Engl J Med 2004 2004; 350: 647-654.
    • (2004) N Engl J Med , vol.2004 , Issue.350 , pp. 647-654
    • Mueller, C.1    Scholer, A.2    Laule-Kilian, K.3
  • 49
    • 0037162372 scopus 로고    scopus 로고
    • B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: Analysis from Breathing Not Properly (BNP) Multinational Study
    • McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002; 106: 416-422.
    • (2002) Circulation , vol.106 , pp. 416-422
    • McCullough, P.A.1    Nowak, R.M.2    McCord, J.3
  • 50
    • 12844281204 scopus 로고    scopus 로고
    • Risk stratification for in-hospital mortality in acutely decompensated heart failure: Classification and regression tree analysis
    • Fonarow GC, Adams KF, Jr., Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005; 293: 572-580.
    • (2005) JAMA , vol.293 , pp. 572-580
    • Fonarow, G.C.1    Adams Jr., K.F.2    Abraham, W.T.3
  • 51
    • 0344420330 scopus 로고    scopus 로고
    • Predicting mortality among patients hospitalized for heart failure: Derivation and validation of a clinical model
    • Lee DS, Austin PC, Rouleau JL, et al. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003; 290: 2581-2587.
    • (2003) JAMA , vol.290 , pp. 2581-2587
    • Lee, D.S.1    Austin, P.C.2    Rouleau, J.L.3
  • 52
    • 34447536189 scopus 로고    scopus 로고
    • Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure
    • Bayes-Genis A, Pascual-Figal D, Fabregat J, et al. Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure. Int J Cardiol 2007; 120: 338-343.
    • (2007) Int J Cardiol , vol.120 , pp. 338-343
    • Bayes-Genis, A.1    Pascual-Figal, D.2    Fabregat, J.3
  • 53
    • 5644268954 scopus 로고    scopus 로고
    • N-Terminal-Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients
    • Bettencourt P, Azevedo A, Pimenta J, et al. N-Terminal-Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients. Circulation 2004 2004; 110: 2168-2174.
    • (2004) Circulation , vol.2004 , Issue.110 , pp. 2168-2174
    • Bettencourt, P.1    Azevedo, A.2    Pimenta, J.3
  • 54
    • 1242295182 scopus 로고    scopus 로고
    • Predischarge B-type natriuretic peptide assay for identifying patients at high risk of readmission after decompensated heart failure
    • Logeart D, Thabut G, Jourdain P, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of readmission after decompensated heart failure. J Am Coll Cardiol 2004; 43: 635-641.
    • (2004) J Am Coll Cardiol , vol.43 , pp. 635-641
    • Logeart, D.1    Thabut, G.2    Jourdain, P.3
  • 55
    • 4444286804 scopus 로고    scopus 로고
    • Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath
    • Maisel A, Hollander JE, Guss D, et al. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 2004; 44: 1328-1333.
    • (2004) J Am Coll Cardiol , vol.44 , pp. 1328-1333
    • Maisel, A.1    Hollander, J.E.2    Guss, D.3
  • 56
    • 1342291268 scopus 로고    scopus 로고
    • N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction
    • Bayes-Genis A, Santalo-Bel M, Zapico-Muniz E, et al. N-terminal probrain natriuretic peptide (NT-proBNP) in the emergency diagnosis and in-hospital monitoring of patients with dyspnoea and ventricular dysfunction. Eur J Heart Fail 2004; 6: 301-308.
    • (2004) Eur J Heart Fail , vol.6 , pp. 301-308
    • Bayes-Genis, A.1    Santalo-Bel, M.2    Zapico-Muniz, E.3
  • 57
    • 33746546703 scopus 로고    scopus 로고
    • B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure
    • Gegenhuber A, Mueller T, Dieplinger B, et al. B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure. Clin Chim Acta 2006; 370: 174-179.
    • (2006) Clin Chim Acta , vol.370 , pp. 174-179
    • Gegenhuber, A.1    Mueller, T.2    Dieplinger, B.3
  • 58
    • 30744458817 scopus 로고    scopus 로고
    • NT-proBNP Testing for Diagnosis and Short-Term Prognosis in Acute Congestive Heart Failure: An International Pooled Analysis of 1256 Patients.The International Collaborative of NT-proBNP (ICON) Study
    • Januzzi JL, Jr., van Kimmenade RRJ, Lainchbury JG, et al. NT-proBNP Testing for Diagnosis and Short-Term Prognosis in Acute Congestive Heart Failure: An International Pooled Analysis of 1256 Patients.The International Collaborative of NT-proBNP (ICON) Study. Eur Heart J 2006; 27: 330-337.
    • (2006) Eur Heart J , vol.27 , pp. 330-337
    • Januzzi Jr., J.L.1    van Kimmenade, R.R.J.2    Lainchbury, J.G.3
  • 59
    • 33644876940 scopus 로고    scopus 로고
    • NT-ProBNP in acute heart failure: Correlation with invasively measured hemodynamic parameters during recompensation
    • Knebel F, Schimke I, Pliet K, et al. NT-ProBNP in acute heart failure: correlation with invasively measured hemodynamic parameters during recompensation. J Card Fail 2005; 11: S38-41.
    • (2005) J Card Fail , vol.11
    • Knebel, F.1    Schimke, I.2    Pliet, K.3
  • 60
    • 0346056801 scopus 로고    scopus 로고
    • Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure
    • Bettencourt P, Frioes F, Azevedo A, et al. Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure. Int J Cardiol 2004; 93: 45-48.
    • (2004) Int J Cardiol , vol.93 , pp. 45-48
    • Bettencourt, P.1    Frioes, F.2    Azevedo, A.3
  • 61
    • 33847322523 scopus 로고    scopus 로고
    • A change in N-terminal pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure
    • Gardner RS, Chong KS, Morton JJ, et al. A change in N-terminal pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure. Eur J Heart Fail 2007; 9: 266-271.
    • (2007) Eur J Heart Fail , vol.9 , pp. 266-271
    • Gardner, R.S.1    Chong, K.S.2    Morton, J.J.3
  • 62
    • 30944450154 scopus 로고    scopus 로고
    • Incremental prognostic value of changes in B-type natriuretic peptide in heart failure
    • Latini R, Masson S, Wong M, et al. Incremental prognostic value of changes in B-type natriuretic peptide in heart failure. Am J Med 2006; 119: 70 e23-30.
    • (2006) Am J Med , vol.119 , Issue.70
    • Latini, R.1    Masson, S.2    Wong, M.3
  • 63
    • 0034176934 scopus 로고    scopus 로고
    • Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
    • Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 2000; 355: 1126-1130.
    • (2000) Lancet , vol.355 , pp. 1126-1130
    • Troughton, R.W.1    Frampton, C.M.2    Yandle, T.G.3
  • 64
    • 34247135389 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: The STARS-BNP Multicenter Study
    • Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 2007; 49: 1733-1739.
    • (2007) J Am Coll Cardiol , vol.49 , pp. 1733-1739
    • Jourdain, P.1    Jondeau, G.2    Funck, F.3
  • 65
    • 27744441700 scopus 로고    scopus 로고
    • Testing new targets of therapy in advanced heart failure: The design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial
    • Shah MR, Claise KA, Bowers MT, et al. Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial. Am Heart J 2005; 150: 893-898.
    • (2005) Am Heart J , vol.150 , pp. 893-898
    • Shah, M.R.1    Claise, K.A.2    Bowers, M.T.3
  • 66
    • 33747233725 scopus 로고    scopus 로고
    • NTproBNP-guided drug treatment for chronic heart failure: Design and methods in the "BATTLESCARRED" trial
    • Lainchbury JG, Troughton RW, Frampton CM, et al. NTproBNP-guided drug treatment for chronic heart failure: design and methods in the "BATTLESCARRED" trial. Eur J Heart Fail 2006; 8: 532-538.
    • (2006) Eur J Heart Fail , vol.8 , pp. 532-538
    • Lainchbury, J.G.1    Troughton, R.W.2    Frampton, C.M.3
  • 67
    • 33646483052 scopus 로고    scopus 로고
    • Management of elderly patients with congestive heart failure-design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)
    • Brunner-La Rocca HP, Buser PT, Schindler R, et al. Management of elderly patients with congestive heart failure-design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Am Heart J 2006; 151: 949-955.
    • (2006) Am Heart J , vol.151 , pp. 949-955
    • Brunner-La Rocca, H.P.1    Buser, P.T.2    Schindler, R.3
  • 68
    • 0038380460 scopus 로고    scopus 로고
    • Increased cardiac BNP expression associated with myocardial ischemia
    • Goetze JP, Christoffersen C, Perko M, et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003; 17: 1105-1107.
    • (2003) FASEB J , vol.17 , pp. 1105-1107
    • Goetze, J.P.1    Christoffersen, C.2    Perko, M.3
  • 69
    • 0028300572 scopus 로고
    • Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium
    • Toth M, Vuorinen KH, Vuolteenaho O, et al. Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. Am J Physiol 1994; 266: H1572-1580.
    • (1994) Am J Physiol , vol.266
    • Toth, M.1    Vuorinen, K.H.2    Vuolteenaho, O.3
  • 70
    • 0029055445 scopus 로고
    • Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris
    • Marumoto K, Hamada M, Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Lond) 1995; 88: 551-556.
    • (1995) Clin Sci (Lond) , vol.88 , pp. 551-556
    • Marumoto, K.1    Hamada, M.2    Hiwada, K.3
  • 71
    • 0034111147 scopus 로고    scopus 로고
    • Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty
    • Kyriakides ZS, Markianos M, Michalis L, et al. Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty. Clin Cardiol 2000; 23: 285-288.
    • (2000) Clin Cardiol , vol.23 , pp. 285-288
    • Kyriakides, Z.S.1    Markianos, M.2    Michalis, L.3
  • 72
    • 3242669017 scopus 로고    scopus 로고
    • B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: An ENTIRE-TIMI-23 substudy
    • Mega JL, Morrow DA, De Lemos JA, et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 2004; 44: 335-339.
    • (2004) J Am Coll Cardiol , vol.44 , pp. 335-339
    • Mega, J.L.1    Morrow, D.A.2    De Lemos, J.A.3
  • 73
    • 42949162624 scopus 로고    scopus 로고
    • Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: Comparison with plasma midregional proatrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study
    • Khan SQ, Dhillon O, Kelly D, et al. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional proatrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 2008; 51: 1857-1864.
    • (2008) J Am Coll Cardiol , vol.51 , pp. 1857-1864
    • Khan, S.Q.1    Dhillon, O.2    Kelly, D.3
  • 74
    • 0035807597 scopus 로고    scopus 로고
    • The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
    • de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-1021.
    • (2001) N Engl J Med , vol.345 , pp. 1014-1021
    • de Lemos, J.A.1    Morrow, D.A.2    Bentley, J.H.3
  • 75
    • 0029948712 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide
    • Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996; 93(11): 1963-1969.
    • (1996) Circulation , vol.93 , Issue.11 , pp. 1963-1969
    • Omland, T.1    Aakvaag, A.2    Bonarjee, V.V.3
  • 76
    • 53549102796 scopus 로고    scopus 로고
    • Prognostic value of the N-terminal pro-B-type natriuretic peptide in the elderly with acute myocardial infarction
    • Drewniak W, Snopek G, Zarukiewicz M, et al. Prognostic value of the N-terminal pro-B-type natriuretic peptide in the elderly with acute myocardial infarction. Kardiol Pol 2008; 66: 750-755.
    • (2008) Kardiol Pol , vol.66 , pp. 750-755
    • Drewniak, W.1    Snopek, G.2    Zarukiewicz, M.3
  • 77
    • 50549104483 scopus 로고    scopus 로고
    • Brain natriuretic peptides as biomarkers for atherosclerosis
    • Summer
    • Ashley KE, Galla JM, Nicholls SJ. Brain natriuretic peptides as biomarkers for atherosclerosis. Prev Cardiol Summer 2008; 11: 172-176.
    • (2008) Prev Cardiol , vol.11 , pp. 172-176
    • Ashley, K.E.1    Galla, J.M.2    Nicholls, S.J.3
  • 78
    • 13744259846 scopus 로고    scopus 로고
    • N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease
    • Kragelund C, Gronning B, Kober L, et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005; 352: 666-675.
    • (2005) N Engl J Med , vol.352 , pp. 666-675
    • Kragelund, C.1    Gronning, B.2    Kober, L.3
  • 79
    • 33846129459 scopus 로고    scopus 로고
    • N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease
    • Bibbins-Domingo K, Gupta R, Na B, et al. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA 2007; 297: 169-176.
    • (2007) JAMA , vol.297 , pp. 169-176
    • Bibbins-Domingo, K.1    Gupta, R.2    Na, B.3
  • 80
    • 26944453575 scopus 로고    scopus 로고
    • Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina
    • Ndrepepa G, Braun S, Niemoller K, et al. Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina. Circulation 2005; 112: 2102-2107.
    • (2005) Circulation , vol.112 , pp. 2102-2107
    • Ndrepepa, G.1    Braun, S.2    Niemoller, K.3
  • 81
    • 33947330983 scopus 로고    scopus 로고
    • Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: The PEACE Trial
    • Omland T, Sabatine MS, Jablonski KA, et al. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. J Am Coll Cardiol 2007; 50: 205-214.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 205-214
    • Omland, T.1    Sabatine, M.S.2    Jablonski, K.A.3
  • 82
    • 13544267531 scopus 로고    scopus 로고
    • Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: Results from the AtheroGene study
    • Schnabel R, Rupprecht HJ, Lackner KJ, et al. Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J 2005; 26: 241-249.
    • (2005) Eur Heart J , vol.26 , pp. 241-249
    • Schnabel, R.1    Rupprecht, H.J.2    Lackner, K.J.3
  • 83
    • 29344462568 scopus 로고    scopus 로고
    • Comparison of B-Type Natriuretic Peptides for Assessment of Cardiac Function and Prognosis in Stable Ischemic Heart Disease
    • Richards AM, Nicholls MG, Espiner EA, et al. Comparison of B-Type Natriuretic Peptides for Assessment of Cardiac Function and Prognosis in Stable Ischemic Heart Disease. J Am Coll Cardiol 2006; 47: 52-60.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 52-60
    • Richards, A.M.1    Nicholls, M.G.2    Espiner, E.A.3
  • 84
    • 33747079319 scopus 로고    scopus 로고
    • Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study
    • Blankenberg S, McQueen MJ, Smieja M, et al. Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2006; 114: 201-208.
    • (2006) Circulation , vol.114 , pp. 201-208
    • Blankenberg, S.1    McQueen, M.J.2    Smieja, M.3
  • 85
    • 0031093725 scopus 로고    scopus 로고
    • Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular endsystolic wall stress in patients with aortic stenosis
    • Ikeda T, Matsuda K, Itoh H, et al. Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular endsystolic wall stress in patients with aortic stenosis. Am Heart J 1997; 133: 307-314.
    • (1997) Am Heart J , vol.133 , pp. 307-314
    • Ikeda, T.1    Matsuda, K.2    Itoh, H.3
  • 86
    • 23744504440 scopus 로고    scopus 로고
    • Transcardiac gradients of N-terminal B-type natriuretic peptide in aortic valve stenosis
    • Kupari M, Turto H, Lommi J, et al. Transcardiac gradients of N-terminal B-type natriuretic peptide in aortic valve stenosis. Eur J Heart Fail 2005; 7: 809-814.
    • (2005) Eur J Heart Fail , vol.7 , pp. 809-814
    • Kupari, M.1    Turto, H.2    Lommi, J.3
  • 87
    • 0034812918 scopus 로고    scopus 로고
    • Natriuretic peptides in patients with aortic stenosis
    • Qi W, Mathisen P, Kjekshus J, et al. Natriuretic peptides in patients with aortic stenosis. Am Heart J 2001; 142: 725-732.
    • (2001) Am Heart J , vol.142 , pp. 725-732
    • Qi, W.1    Mathisen, P.2    Kjekshus, J.3
  • 88
    • 0035143708 scopus 로고    scopus 로고
    • Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis
    • Talwar S, Downie PF, Squire IB, et al. Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis. Eur J Heart Fail 2001; 3: 15-19.
    • (2001) Eur J Heart Fail , vol.3 , pp. 15-19
    • Talwar, S.1    Downie, P.F.2    Squire, I.B.3
  • 89
    • 0037446572 scopus 로고    scopus 로고
    • Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis
    • Gerber IL, Stewart RA, Legget ME, et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 2003; 107: 1884-1890.
    • (2003) Circulation , vol.107 , pp. 1884-1890
    • Gerber, I.L.1    Stewart, R.A.2    Legget, M.E.3
  • 90
    • 15244343617 scopus 로고    scopus 로고
    • Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration
    • Gerber IL, Legget ME, West TM, et al. Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration. Am J Cardiol 2005; 95: 898-901.
    • (2005) Am J Cardiol , vol.95 , pp. 898-901
    • Gerber, I.L.1    Legget, M.E.2    West, T.M.3
  • 91
    • 20244386663 scopus 로고    scopus 로고
    • Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis
    • Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004; 109: 2302-2308.
    • (2004) Circulation , vol.109 , pp. 2302-2308
    • Bergler-Klein, J.1    Klaar, U.2    Heger, M.3
  • 92
    • 18844424345 scopus 로고    scopus 로고
    • Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease
    • Weber M, Arnold R, Rau M, et al. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J 2005; 26: 1023-1030.
    • (2005) Eur Heart J , vol.26 , pp. 1023-1030
    • Weber, M.1    Arnold, R.2    Rau, M.3
  • 93
    • 4444340383 scopus 로고    scopus 로고
    • Elevated B-type natriuretic peptide in asymptomatic men with chronic aortic regurgitation and preserved left ventricular systolic function
    • Eimer MJ, Ekery DL, Rigolin VH, et al. Elevated B-type natriuretic peptide in asymptomatic men with chronic aortic regurgitation and preserved left ventricular systolic function. Am J Cardiol 2004; 94: 676-678.
    • (2004) Am J Cardiol , vol.94 , pp. 676-678
    • Eimer, M.J.1    Ekery, D.L.2    Rigolin, V.H.3
  • 94
    • 23044516394 scopus 로고    scopus 로고
    • Brain natriuretic peptide and the severity of aortic regurgitation: Is there any correlation?
    • Ozkan M, Baysan O, Erinc K, et al. Brain natriuretic peptide and the severity of aortic regurgitation: is there any correlation? J Int Med Res 2005; 33: 454-459.
    • (2005) J Int Med Res , vol.33 , pp. 454-459
    • Ozkan, M.1    Baysan, O.2    Erinc, K.3
  • 95
    • 33646907966 scopus 로고    scopus 로고
    • Valvular aortic stenosis: Disease severity and timing of intervention
    • Otto CM. Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol 2006; 47: 2141-2151.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 2141-2151
    • Otto, C.M.1
  • 96
    • 0038308841 scopus 로고    scopus 로고
    • Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation
    • Sutton TM, Stewart RAH, Gerber IL, et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003; 41: 2280-2287.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 2280-2287
    • Sutton, T.M.1    Stewart, R.A.H.2    Gerber, I.L.3
  • 97
    • 33646176454 scopus 로고    scopus 로고
    • Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation
    • Yusoff R, Clayton N, Keevil B, et al. Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation. Am J Cardiol 2006; 97: 1498-1501.
    • (2006) Am J Cardiol , vol.97 , pp. 1498-1501
    • Yusoff, R.1    Clayton, N.2    Keevil, B.3
  • 98
    • 0030731759 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide concentrations in patients with chronic mitral regurgitation
    • Brookes CI, Kemp MW, Hooper J, et al. Plasma brain natriuretic peptide concentrations in patients with chronic mitral regurgitation. J Heart Valve Dis 1997; 6: 608-612.
    • (1997) J Heart Valve Dis , vol.6 , pp. 608-612
    • Brookes, C.I.1    Kemp, M.W.2    Hooper, J.3
  • 99
    • 33644639372 scopus 로고    scopus 로고
    • Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation
    • Shang YP, Lai L, Chen J, et al. Effects of percutaneous balloon mitral valvuloplasty on plasma B-type natriuretic peptide in rheumatic mitral stenosis with and without atrial fibrillation. J Heart Valve Dis 2005; 14: 453-459.
    • (2005) J Heart Valve Dis , vol.14 , pp. 453-459
    • Shang, Y.P.1    Lai, L.2    Chen, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.